Anti-Vegf in Complications of Proliferative Diabetic Rethinopathy

Abstract

This paper has the purpose to analyse the relevance of the use of angiogenesis inhibitors (anti-VEGF drugs) in the treatment of the proliferative stage of diabetic retinopathy. The literature review was carried out using the search engines PubMed, the Library, and the analysis of literature sources, 30 in number, published from 2000 to 2024. In patients with complicated cases of proliferative diabetic retinopathy, pre-intravitreal injection of angiogenesis inhibitors provides the most gentle approach to surgical treatment, which improves the anatomical and functional results of vitreoretinal surgery and helps reduce the number of intra- and postoperative complications.